Bio Net Debt from 2010 to 2026

TECH Stock

USD 57.92 0.05 0.09%

Bio Techne's Net Debt is increasing with slightly volatile movements from year to year. Net Debt is estimated to finish at about 340.4 M this year. Net Debt is the total debt of Bio Techne Corp minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

1989-09-30

Previous Quarter

249.5 M

Current Value

178 M

Quarterly Volatility

161.1 M

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check Bio Techne financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Techne's main balance sheet or income statement drivers, such as Depreciation And Amortization of 132.7 M, Total Revenue of 1.5 B or Gross Profit of 954.3 M, as well as many indicators such as Price To Sales Ratio of 6.86, Dividend Yield of 0.0106 or PTB Ratio of 6.72. Bio financial statements analysis is a perfect complement when working with Bio Techne Valuation or Volatility modules.

Build AI portfolio with Bio Stock

Check out the analysis of Bio Techne Correlation against competitors.

The Net Debt trend for Bio Techne Corp offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Bio Techne is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Bio Techne's Net Debt Growth Pattern

Below is the plot of the Net Debt of Bio Techne Corp over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Bio Techne's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bio Techne's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Bio Net Debt Regression Statistics

	Arithmetic Mean	151,436,720
	Geometric Mean	144,203,416
	Coefficient Of Variation	131.25
	Mean Deviation	160,478,273
	Median	221,463,000
	Standard Deviation	198,759,832
	Sample Variance	39505.5T
	Range	709.9M
	R-Value	0.78
	Mean Square Error	16803.6T
	R-Squared	0.60
	Significance	0.0003
	Slope	30,519,765
	Total Sum of Squares	632087.5T

Bio Net Debt History

	2026	340.4 M
	2025	324.2 M
	2024	281.9 M
	2023	267.7 M
	2022	274.4 M
	2021	153.4 M
	2020	221.5 M

Other Fundumenentals of Bio Techne Corp

Net Debt To E B I T D A

Bio Techne Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Intangible Assets	Short Term Investments	Common Stock	Long Term Debt	Property Plant Equipment	Good Will	Current Deferred Revenue	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Long Term Debt Total	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.78	0.96	0.98	0.92	0.9	0.75	0.61	0.8	-0.49	0.83	0.84	0.79	0.98	0.92	0.17	0.94	0.74	0.51	-0.04	0.79	0.19	0.91	0.71
Total Stockholder Equity	0.98		0.68	0.95	0.98	0.84	0.94	0.72	0.58	0.7	-0.48	0.88	0.74	0.76	0.95	0.91	0.32	0.96	0.64	0.59	-0.08	0.69	0.21	0.91	0.76
Net Debt	0.78	0.68		0.69	0.76	0.92	0.47	0.55	0.55	0.85	-0.45	0.49	0.94	0.56	0.85	0.79	-0.27	0.67	0.78	0.29	0.09	0.9	0.23	0.69	0.46
Retained Earnings	0.96	0.95	0.69		0.93	0.87	0.9	0.73	0.64	0.82	-0.37	0.75	0.77	0.8	0.92	0.8	0.13	0.85	0.71	0.37	-0.01	0.73	0.11	0.85	0.62
Net Receivables	0.98	0.98	0.76	0.93		0.88	0.87	0.66	0.62	0.75	-0.57	0.89	0.8	0.73	0.97	0.94	0.26	0.95	0.72	0.57	-0.04	0.75	0.22	0.91	0.77
Total Liab	0.92	0.84	0.92	0.87	0.88		0.72	0.75	0.63	0.93	-0.44	0.61	0.97	0.75	0.95	0.84	-0.19	0.79	0.88	0.28	0.06	0.93	0.13	0.8	0.5
Total Current Assets	0.9	0.94	0.47	0.9	0.87	0.72		0.74	0.5	0.58	-0.26	0.81	0.63	0.73	0.82	0.74	0.35	0.87	0.56	0.52	-0.06	0.61	0.16	0.84	0.65
Short Term Debt	0.75	0.72	0.55	0.73	0.66	0.75	0.74		0.48	0.73	-0.1	0.49	0.63	0.88	0.73	0.65	-0.08	0.71	0.65	0.1	-0.07	0.61	-0.12	0.74	0.23
Accounts Payable	0.61	0.58	0.55	0.64	0.62	0.63	0.5	0.48		0.66	-0.33	0.41	0.6	0.52	0.63	0.54	-0.13	0.49	0.61	0.04	0.71	0.57	0.07	0.57	0.29
Intangible Assets	0.8	0.7	0.85	0.82	0.75	0.93	0.58	0.73	0.66		-0.35	0.41	0.88	0.77	0.83	0.67	-0.38	0.62	0.86	-0.02	0.1	0.85	-0.08	0.68	0.29
Short Term Investments	-0.49	-0.48	-0.45	-0.37	-0.57	-0.44	-0.26	-0.1	-0.33	-0.35		-0.54	-0.42	-0.25	-0.57	-0.68	-0.26	-0.57	-0.38	-0.42	0.03	-0.36	-0.23	-0.45	-0.6
Common Stock	0.83	0.88	0.49	0.75	0.89	0.61	0.81	0.49	0.41	0.41	-0.54		0.5	0.56	0.79	0.87	0.59	0.93	0.43	0.77	-0.16	0.46	0.22	0.84	0.84
Long Term Debt	0.84	0.74	0.94	0.77	0.8	0.97	0.63	0.63	0.6	0.88	-0.42	0.5		0.61	0.88	0.76	-0.28	0.69	0.86	0.26	0.16	0.98	0.21	0.72	0.46
Property Plant Equipment	0.79	0.76	0.56	0.8	0.73	0.75	0.73	0.88	0.52	0.77	-0.25	0.56	0.61		0.76	0.69	0.02	0.73	0.72	0.14	-0.09	0.62	-0.04	0.82	0.46
Good Will	0.98	0.95	0.85	0.92	0.97	0.95	0.82	0.73	0.63	0.83	-0.57	0.79	0.88	0.76		0.95	0.08	0.92	0.77	0.46	-0.01	0.82	0.23	0.88	0.67
Current Deferred Revenue	0.92	0.91	0.79	0.8	0.94	0.84	0.74	0.65	0.54	0.67	-0.68	0.87	0.76	0.69	0.95		0.27	0.96	0.65	0.62	-0.08	0.69	0.26	0.89	0.75
Net Tangible Assets	0.17	0.32	-0.27	0.13	0.26	-0.19	0.35	-0.08	-0.13	-0.38	-0.26	0.59	-0.28	0.02	0.08	0.27		0.41	-0.28	0.74	-0.3	-0.29	0.2	0.31	0.62
Capital Surpluse	0.94	0.96	0.67	0.85	0.95	0.79	0.87	0.71	0.49	0.62	-0.57	0.93	0.69	0.73	0.92	0.96	0.41		0.59	0.69	-0.14	0.64	0.18	0.94	0.8
Deferred Long Term Liab	0.74	0.64	0.78	0.71	0.72	0.88	0.56	0.65	0.61	0.86	-0.38	0.43	0.86	0.72	0.77	0.65	-0.28	0.59		0.07	0.13	0.86	0.09	0.66	0.36
Long Term Investments	0.51	0.59	0.29	0.37	0.57	0.28	0.52	0.1	0.04	-0.02	-0.42	0.77	0.26	0.14	0.46	0.62	0.74	0.69	0.07		-0.23	0.26	0.4	0.58	0.85
Short Long Term Debt	-0.04	-0.08	0.09	-0.01	-0.04	0.06	-0.06	-0.07	0.71	0.1	0.03	-0.16	0.16	-0.09	-0.01	-0.08	-0.3	-0.14	0.13	-0.23		0.16	0.02	-0.01	-0.14
Long Term Debt Total	0.79	0.69	0.9	0.73	0.75	0.93	0.61	0.61	0.57	0.85	-0.36	0.46	0.98	0.62	0.82	0.69	-0.29	0.64	0.86	0.26	0.16		0.26	0.72	0.47
Net Invested Capital	0.19	0.21	0.23	0.11	0.22	0.13	0.16	-0.12	0.07	-0.08	-0.23	0.22	0.21	-0.04	0.23	0.26	0.2	0.18	0.09	0.4	0.02	0.26		0.18	0.47
Net Working Capital	0.91	0.91	0.69	0.85	0.91	0.8	0.84	0.74	0.57	0.68	-0.45	0.84	0.72	0.82	0.88	0.89	0.31	0.94	0.66	0.58	-0.01	0.72	0.18		0.77
Capital Stock	0.71	0.76	0.46	0.62	0.77	0.5	0.65	0.23	0.29	0.29	-0.6	0.84	0.46	0.46	0.67	0.75	0.62	0.8	0.36	0.85	-0.14	0.47	0.47	0.77

Click cells to compare fundamentals

About Bio Techne Financial Statements

Investors use fundamental indicators, such as Bio Techne's Net Debt, to determine how well the company is positioned to perform in the future. Although Bio Techne's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.

	Last Reported	Projected for Next Year
Net Debt	324.2 M	340.4 M
Net Debt To EBITDA	1.17	1.23

Currently Active Assets on Macroaxis

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill
CSAN	Cosan SA ADR
RKT	Rocket Companies

When determining whether Bio Techne Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Techne's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Techne Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Techne Corp Stock:

How To Invest In Bio

Details

Is Bio Stock a good investment?

Details

What is Bio Techne's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Bio Techne Correlation against competitors.

You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Is there potential for Life Sciences Tools & Services market expansion? Will Bio introduce new products? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.091

Dividend Share

0.32

Earnings Share

0.53

Revenue Per Share

7.787

Quarterly Revenue Growth

(0)

Understanding Bio Techne Corp requires distinguishing between market price and book value, where the latter reflects Bio's accounting equity. The concept of intrinsic value - what Bio Techne's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Bio Techne's price substantially above or below its fundamental value.

Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Bio Techne's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Bio Net Debt from 2010 to 2026

Latest Bio Techne's Net Debt Growth Pattern

Bio Net Debt Regression Statistics

Bio Net Debt History

Other Fundumenentals of Bio Techne Corp

Bio Techne Net Debt component correlations

About Bio Techne Financial Statements

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY